NYSE: MTD |
| Healthcare / Medical Diagnostics & Research / USA |
1 146.90 | +14.50 | +1.28% | Vol 245.14K | 1Y Perf -16.45% |
Jun 24th, 2022 16:00 DELAYED |
BID | 1 144.31 | ASK | 1 831.64 | ||
Open | 1 138.16 | Previous Close | 1 132.40 | ||
Pre-Market | - | After-Market | 1 146.90 | ||
- - | - -% |
Target Price | 1 343.00 | Analyst Rating | Hold 3.33 | |
Potential % | 17.10 | Finscreener Ranking | + 37.58 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★ 38.90 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★★★ 58.28 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 10.15 | Earnings Rating | Buy | |
Market Cap | 26.01B | Earnings Date | 4th Aug 2022 | |
Alpha | 0.01 | Standard Deviation | 0.08 | |
Beta | 1.06 |
Today's Price Range 1 135.401 152.95 | 52W Range 1 082.781 714.75 | 5 Year PE Ratio Range 25.2068.80 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | 4.47% | ||
1 Month | -6.76% | ||
3 Months | -17.39% | ||
6 Months | -29.47% | ||
1 Year | -16.45% | ||
3 Years | 38.85% | ||
5 Years | 91.26% | ||
10 Years | 661.71% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 90.15 | |||
ROE last 12 Months | 552.43 | |||
ROA (5Y Avg) | 12.11 | |||
ROA last 12 Months | 24.85 | |||
ROC (5Y Avg) | 29.78 | |||
ROC last 12 Months | 44.00 | |||
Return on invested Capital Q | 9.62 | |||
Return on invested Capital Y | 12.96 | |||
Assets Turnover | 0.50 | |||
Receivables Turnover | 2.70 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
32.30 | ||||
294.41 | ||||
6.53 | ||||
30.40 | ||||
35.90 | ||||
36.09 | ||||
-28.60 | ||||
3.73 | ||||
26.65B | ||||
Forward PE | 26.20 | |||
PEG | 1.69 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.70 | ||||
1.20 | ||||
0.95 | ||||
22.14 | ||||
22.70 | ||||
Leverage Ratio | 21.50 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
58.20 | ||||
26.80 | ||||
29.70 | ||||
24.40 | ||||
20.81 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
3.81B | ||||
168.05 | ||||
7.72 | ||||
6.78 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2022 | 7.32 | 7.87 | 7.51 |
Q04 2021 | 10.07 | 10.53 | 4.57 |
Q03 2021 | 8.25 | 8.72 | 5.70 |
Q02 2021 | 7.64 | 8.10 | 6.02 |
Q01 2021 | 5.65 | 6.56 | 16.11 |
Q04 2020 | 8.72 | 9.26 | 6.19 |
Q03 2020 | 6.02 | 7.02 | 16.61 |
Q02 2020 | 4.27 | 5.29 | 23.89 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
6/2022 QR | 8.78 | 0.00 | - |
9/2022 QR | 9.72 | -3.67 | Negative |
12/2022 FY | 38.35 | -0.03 | Negative |
12/2023 FY | 42.68 | 0.28 | Positive |
Next Report Date | 4th Aug 2022 |
Estimated EPS Next Report | 8.78 |
Estimates Count | 4 |
EPS Growth Next 5 Years % | 19.10 |
Volume Overview | |
---|---|
Volume | 245.14K |
Shares Outstanding | 22.68K |
Shares Float | 19.81M |
Trades Count | 9.57K |
Dollar Volume | 280.84M |
Avg. Volume | 156.02K |
Avg. Weekly Volume | 208.22K |
Avg. Monthly Volume | 125.75K |
Avg. Quarterly Volume | 134.08K |
Mettler-Toledo International Inc. (NYSE: MTD) stock closed at 1146.9 per share at the end of the most recent trading day (a 1.28% change compared to the prior day closing price) with a volume of 245.14K shares and market capitalization of 26.01B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 16500 people. Mettler-Toledo International Inc. CEO is Olivier A. Filliol.
The one-year performance of Mettler-Toledo International Inc. stock is -16.45%, while year-to-date (YTD) performance is -32.42%. MTD stock has a five-year performance of 91.26%. Its 52-week range is between 1082.78 and 1714.75, which gives MTD stock a 52-week price range ratio of 10.15%
Mettler-Toledo International Inc. currently has a PE ratio of 32.30, a price-to-book (PB) ratio of 294.41, a price-to-sale (PS) ratio of 6.53, a price to cashflow ratio of 30.40, a PEG ratio of 2.32, a ROA of 24.85%, a ROC of 44.00% and a ROE of 552.43%. The company’s profit margin is 20.81%, its EBITDA margin is 29.70%, and its revenue ttm is $3.81 Billion , which makes it $168.05 revenue per share.
Of the last four earnings reports from Mettler-Toledo International Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $8.78 for the next earnings report. Mettler-Toledo International Inc.’s next earnings report date is 04th Aug 2022.
The consensus rating of Wall Street analysts for Mettler-Toledo International Inc. is Hold (3.33), with a target price of $1343, which is +17.10% compared to the current price. The earnings rating for Mettler-Toledo International Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Mettler-Toledo International Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Mettler-Toledo International Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.58, ATR14 : 39.42, CCI20 : -62.36, Chaikin Money Flow : -0.05, MACD : -42.13, Money Flow Index : 30.09, ROC : -12.80, RSI : 41.20, STOCH (14,3) : 26.89, STOCH RSI : 1.00, UO : 40.16, Williams %R : -73.11), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Mettler-Toledo International Inc. in the last 12-months were: Christian Magloth (Option Excercise at a value of $1 071 627), Christian Magloth (Sold 4 760 shares of value $6 823 304 ), Gerry Keller (Option Excercise at a value of $710 660), Gerry Keller (Sold 1 331 shares of value $1 721 324 ), Marc De La Gueroniere (Option Excercise at a value of $1 868 172), Marc De La Gueroniere (Sold 7 254 shares of value $11 147 482 ), Olivier A. Filliol (Option Excercise at a value of $28 444 967), Olivier A. Filliol (Sold 143 808 shares of value $208 055 851 ), Peter Aggersbjerg (Option Excercise at a value of $1 984 197), Peter Aggersbjerg (Sold 3 491 shares of value $4 711 087 ), Robert F. Spoerry (Option Excercise at a value of $1 069 137), Robert F. Spoerry (Sold 5 290 shares of value $7 547 000 ), Shawn Vadala (Option Excercise at a value of $804 585), Shawn Vadala (Sold 4 781 shares of value $6 906 775 ), Thomas P. Salice (Sold 8 700 shares of value $12 900 482 ), Wah-Hui Chu (Option Excercise at a value of $343 438), Wah-Hui Chu (Sold 625 shares of value $814 200 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Hold | Hold | Hold |
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (54% of 2020 sales), industrial (40%), and food retail industries (6%). Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with sales distribution roughly as follows: the United States around 30% of sales, Europe around 30%, China around 20%, and the rest of the world around 20%.
CEO: Olivier A. Filliol
Telephone: +1 614 438-4511
Address: 1900 Polaris Parkway, Columbus 43240, OH, US
Number of employees: 16 500
Sat, 07 May 2022 03:32 GMT Mettler-Toledo (MTD) Gets a Hold Rating from Robert W. Baird
- TipRanks. All rights reserved.Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.